US Patent Issued to Seattle Children's Hospital on Jan. 13 for "Antibodies that specifically bind peptides associated with the primary immunodeficiencies: Wiskott-Aldrich syndrome and x-linked agammaglobulinemia" (Washington Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,523,662, issued on Jan. 13, was assigned to Seattle Children's Hospital (Seattle).

"Antibodies that specifically bind peptides associated with the primary immunodeficiencies: Wiskott-Aldrich syndrome and x-linked agammaglobulinemia" was invented by Sihoun Hahn (Clyde Hill, Wash.), Christopher Collins (Seattle), Fan Yi (Shoreline, Wash.) and Remwilyn Dayuha (Lynnwood, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The current disclosure provides antibodies that bind to peptides associated with the primary immunodeficiency disorders (PIDD) Wiskott-Aldrich Syndrome (WAS) and X-linked agammaglobulinemia (XLA). The antibodies can be used in peptide imm...